Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-283

Hi Topboy,
Well done on topping up. The CEO and COO were both in the US last week and met with the tablet manufacturer Syngene and had a meeting at Massachusetts general. [Healey] So one assumption is that it was a pre planning meeting and things are on track. So this year remains the official target. The Healey platform will expedite recruitment due to their network and reputation, this is important as almost all trials of every kind struggle to recruit patients in a timely manner. Some even fail to recruit any at all. Healey selection is a very big thing and a great leg up.

Additionally the results of the pre clinical work on Parkinsons and Alzhimer's could be announced shortly after that, or at lest this year as well. Remember the CEO stated in an interview they had asked big Pharma what they wanted to see as a result of the testing, so this has the potential to really kick things ahead. [Speculation on my part only, so give it some thought and reach your own conclusion]

Hope this helps.

Cheers